ArticleCancer biology & therapy2016

Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer.

Adam C ElNaggar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.